← Leaderboards
Anandi Nayan Sheth
University Of Miami School Of Medicine
$14,479,163
Attributed
$47,793,870
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14.3M · FY2014–25$20M$15M$10M$5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,581,998 · 8
By mechanism
R01$21,735,956 · 2
U01$21,569,241 · 1
U19$7,788,128 · 1
KL2$1,525,261 · 1
UG1$1,157,799 · 1
K12$907,200 · 1
Top collaborators
- Gina Maria Wingood14 shared
- Ighovwerha Ofotokun13 shared
- Maria Luisa Alcaide9 shared
- Elizabeth T Golub8 shared
- Seble G Kassaye8 shared
- Aadia Rana8 shared
- Daniel J Westreich8 shared
- Jessica A Sales5 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Lisa R Metsch$46,121,041
- Gbenga Godwin Ogedegbe$43,167,440
- Jose Szapocznik$79,209,602
- Savita Pahwa$35,297,534
- Daniel J Feaster$37,999,274
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanSiteWomen&AposResearch PersonnelCommunitiesCaringAffectMultidisciplinaryEpidemicLeadershipTrainingStructureParticipantRecruitScientistBiologicalEnrollmentFundingCohortPopulation HeterogeneitySpecimenCohort StudiesSciencePositioning Attribute
Grant awards (38)
Study of Treatment And Reproductive outcomes$7,788,128
U19 · FY2025 · HD
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$2,948,385
U01 · FY2025 · HL
Institutional Career Development Core$1,525,261
KL2 · FY2025 · TR
Emory University BIRCWH Program$907,200
K12 · FY2025 · AR · contact PI
An Interactive Systems Approach to Ending the HIV Epidemic Among Women in Atlanta$649,774
R01 · FY2025 · MH
Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH)$519,320
UG1 · FY2025 · CA
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$3,672,647
R01 · FY2024 · HD
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$2,995,554
U01 · FY2024 · HL
An Interactive Systems Approach to Ending the HIV Epidemic Among Women in Atlanta$648,716
R01 · FY2024 · MH
Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH)$313,858
UG1 · FY2024 · CA
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$3,034,067
U01 · FY2023 · HL
An Interactive Systems Approach to Ending the HIV Epidemic Among Women in Atlanta$654,762
R01 · FY2023 · MH
Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH)$324,621
UG1 · FY2023 · CA
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$3,767,324
R01 · FY2022 · HD
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$3,027,878
U01 · FY2022 · HL
An Interactive Systems Approach to Ending the HIV Epidemic Among Women in Atlanta$662,241
R01 · FY2022 · MH
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$3,845,346
R01 · FY2021 · HD
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$3,041,145
U01 · FY2021 · HL
An Interactive Systems Approach to Ending the HIV Epidemic Among Women in Atlanta$757,747
R01 · FY2021 · MH
COVID Vaccine Study OAR Supplement to MWCCS$34,352
U01 · FY2021 · HL
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$3,035,518
R01 · FY2020 · HD
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$2,940,935
U01 · FY2020 · HL
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$601,354
U01 · FY2020 · HL
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$518,860
R01 · FY2020 · HD
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$500,000
R01 · FY2020 · HD
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$122,231
R01 · FY2020 · HD
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$28,408
U01 · FY2020 · HL
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$20,152
U01 · FY2020 · HL
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$4,325
U01 · FY2020 · HL
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$2,900,790
R01 · FY2019 · HD
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$2,435,000
U01 · FY2019 · HL
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$423,887
U01 · FY2019 · HL
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site$33,799
U01 · FY2019 · HL
Characterization and modulation of mucosal immunity for HIV prevention in women$188,499
K23 · FY2018 · AI · contact PI
Characterization and modulation of mucosal immunity for HIV prevention in women$188,346
K23 · FY2017 · AI · contact PI
Characterization and modulation of mucosal immunity for HIV prevention in women$174,036
K23 · FY2016 · AI · contact PI
Characterization and modulation of mucosal immunity for HIV prevention in women$173,496
K23 · FY2015 · AI · contact PI
Characterization and modulation of mucosal immunity for HIV prevention in women$174,036
K23 · FY2014 · AI · contact PI